ascendis pharma glp-1 has granted Novo Nordisk an exclusive worldwide license for the TransCon platform to develop and commercialize products for metabolic diseases, including obesity and type 2 diabetes, along with a product-specific and metabolic balance so energy feels steadier and fullness feels more natural throughout the day. Novo Nordisk signs deal for

Hewitt, P

MRI-guided histology of TDP-43 knock-in mice implicates parvalbumin interneuron loss, impaired neurogenesis and aberrant neurodevelopment in amyotrophic lateral sclerosis-frontotemporal dementia

Plasminogen Activators The plasminogen activators also are useful for controlling coagulation

Those with pain-related sleep issues: DSIP's analgesic properties combined with sleep enhancement could break the pain-sleep disruption cycle

A study just came out that showed if you stop it cold turkey, a majority of those people will gain the weight back

One antioxidant in particular, glutathione, has gained a lot of attention in recent years for its impressive benefits